Lumexa Imaging Holdings, Inc. Common Stock Net Assets
Lumexa Imaging Holdings, Inc. Common Stock net assets. Based on the latest financial reports, Lumexa Imaging Holdings, Inc. Common Stock (LMRI) has net assets worth $615.06 Million USD as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.81 Billion) and total liabilities ($1.19 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See Lumexa Imaging Holdings, Inc. Common Sto net asset quality index to measure how much of total assets are equity-financed.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $615.06 Million |
| % of Total Assets | 34.0% |
| Annual Growth Rate | 71.8% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 140.56 |
Net Assets of Lumexa Imaging Holdings, Inc. Common Stock (2023–2025)
Net assets of Lumexa Imaging Holdings, Inc. Common Stock from 2023 to 2025. This chart illustrates how Lumexa Imaging Holdings, Inc. Common Stock's net assets have evolved over time, based on quarterly financial data. Also explore net asset growth rate of Lumexa Imaging Holdings, Inc. Common Sto to track the company's year-over-year net asset growth rate.
Annual Net Assets for Lumexa Imaging Holdings, Inc. Common Stock (2023–2025)
The table below shows the annual net assets of Lumexa Imaging Holdings, Inc. Common Stock from 2023 to 2025. For live market cap and overall valuation, see LMRI stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $586.12 Million | +262.58% |
| 2024-12-31 | $161.65 Million | -18.53% |
| 2023-12-31 | $198.43 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Lumexa Imaging Holdings, Inc. Common Stock's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 14120300000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Lumexa Imaging Holdings, Inc. Common Stock Net Assets Breakdown (December 2025)
Lumexa Imaging Holdings, Inc. Common Stock net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $96.00K | 0.02% |
| Other Components | $1.22 Billion | 207.65% |
| Total Equity | $586.12 Million | 100.00% |
Lumexa Imaging Holdings, Inc. Common Stock Competitors by Market Cap
The table below lists competitors of Lumexa Imaging Holdings, Inc. Common Stock ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
OCI Co Ltd
KO:010060
|
$1.08 Billion |
|
Highpeak Energy Acquisition Corp
NASDAQ:HPK
|
$1.08 Billion |
|
Manchester United Ltd
F:MUF
|
$1.09 Billion |
|
Hunan Valin Wire & Cable Co Ltd
SHE:001208
|
$1.09 Billion |
|
Ji'an Mankun Technology Co. Ltd. A
SHE:301132
|
$1.08 Billion |
|
Hunan Fazhan Industrial Co Ltd
SHE:000722
|
$1.08 Billion |
|
CONMED Corporation
NYSE:CNMD
|
$1.08 Billion |
|
Tinavi Medical Technologies Co Ltd
SHG:688277
|
$1.08 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Lumexa Imaging Holdings, Inc. Common Stock's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 161,654,000 to 586,123,000, a change of 424,469,000 (262.6%).
- Net loss of 47,104,000 reduced equity.
- New share issuances of 435,585,000 increased equity.
- Other factors increased equity by 35,988,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-47.10 Million | -8.04% |
| Share Issuances | $435.58 Million | +74.32% |
| Other Changes | $35.99 Million | +6.14% |
| Total Change | $- | 262.58% |
Book Value vs Market Value Analysis
This analysis compares Lumexa Imaging Holdings, Inc. Common Stock's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.41x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 5.56x to 1.41x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2023-12-31 | $2.10 | $11.67 | x |
| 2024-12-31 | $1.71 | $11.67 | x |
| 2025-12-31 | $8.26 | $11.67 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Lumexa Imaging Holdings, Inc. Common Stock utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -8.04%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -4.60%
- • Asset Turnover: 0.58x
- • Equity Multiplier: 3.01x
- Recent ROE (-8.04%) is above the historical average (-42.61%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2023 | -61.60% | -13.06% | 0.56x | 8.42x | $-142.07 Million |
| 2024 | -58.21% | -9.92% | 0.57x | 10.33x | $-110.26 Million |
| 2025 | -8.04% | -4.60% | 0.58x | 3.01x | $-105.72 Million |
Industry Comparison
This section compares Lumexa Imaging Holdings, Inc. Common Stock's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $2,467,017,896
- Average return on equity (ROE) among peers: -49.52%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI) | $615.06 Million | -61.60% | 1.94x | $1.08 Billion |
| Abbott Laboratories (ABT) | $24.08 Billion | 18.37% | 0.83x | $179.28 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-132.02 Million | 0.00% | 0.00x | $2.72 Million |
| Aethlon Medical Inc (AEMD) | $-2.20 Million | 0.00% | 0.00x | $1.11 Million |
| Acutus Medical Inc (AFIB) | $75.02 Million | -52.81% | 0.78x | $903.35K |
| Adapthealth Corp (AHCO) | $280.85 Million | -57.55% | 5.46x | $792.23 Million |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.28 Million | -44.54% | 0.25x | $2.40 Million |
| Allurion Technologies, Inc. (ALUR) | $19.83K | -26.07% | 15.64x | $21.01K |
| Autonomix Medical, Inc. Common Stock (AMIX) | $644.00K | -309.01% | 0.34x | $2.01 Million |
| Artivion Inc (AORT) | $300.73 Million | -4.93% | 1.64x | $1.03 Billion |
| Apyx Medical Inc (APYX) | $63.86 Million | -18.63% | 0.16x | $105.31 Million |
About Lumexa Imaging Holdings, Inc. Common Stock
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was foun… Read more